
Antibody-based therapies for COVID-19: Can Europe move faster?
Author(s) -
Michel D. Kazatchkine,
Michel Goldman,
JeanLouis Vincent
Publication year - 2020
Publication title -
plos medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.847
H-Index - 228
eISSN - 1549-1676
pISSN - 1549-1277
DOI - 10.1371/journal.pmed.1003127
Subject(s) - covid-19 , pandemic , coronavirus , virology , medicine , immunotherapy , antibody therapy , antibody , immunology , infectious disease (medical specialty) , immune system , outbreak , monoclonal antibody , pathology , disease
Michel Goldman and colleagues call on the European medical and scientific community to coordinate efforts on immunotherapy-based approaches to coronavirus.